nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—CYP2A6—Ifosfamide—germ cell cancer	0.282	0.554	CbGbCtD
Ezogabine—UGT1A1—Etoposide—germ cell cancer	0.227	0.446	CbGbCtD
Ezogabine—KCNQ4—cochlea—germ cell cancer	0.0393	0.137	CbGeAlD
Ezogabine—KCNQ4—internal ear—germ cell cancer	0.0373	0.13	CbGeAlD
Ezogabine—NAT2—urine—germ cell cancer	0.0262	0.0912	CbGeAlD
Ezogabine—KCNQ4—ear—germ cell cancer	0.0251	0.0874	CbGeAlD
Ezogabine—NAT2—pineal body—germ cell cancer	0.0249	0.0866	CbGeAlD
Ezogabine—UGT1A1—urine—germ cell cancer	0.0097	0.0338	CbGeAlD
Ezogabine—Neurological symptom—Cisplatin—germ cell cancer	0.00728	0.0358	CcSEcCtD
Ezogabine—KCNQ4—eye—germ cell cancer	0.00661	0.023	CbGeAlD
Ezogabine—KCNQ4—retina—germ cell cancer	0.00655	0.0228	CbGeAlD
Ezogabine—KCNQ5—eye—germ cell cancer	0.00643	0.0224	CbGeAlD
Ezogabine—KCNQ5—retina—germ cell cancer	0.00637	0.0222	CbGeAlD
Ezogabine—Raised liver function tests—Dactinomycin—germ cell cancer	0.00603	0.0296	CcSEcCtD
Ezogabine—Nystagmus—Vinblastine—germ cell cancer	0.00494	0.0243	CcSEcCtD
Ezogabine—KCNQ2—brainstem—germ cell cancer	0.00488	0.017	CbGeAlD
Ezogabine—KCNQ2—eye—germ cell cancer	0.00475	0.0165	CbGeAlD
Ezogabine—KCNQ3—telencephalon—germ cell cancer	0.0047	0.0164	CbGeAlD
Ezogabine—NAT2—endocrine gland—germ cell cancer	0.00435	0.0151	CbGeAlD
Ezogabine—KCNQ2—telencephalon—germ cell cancer	0.00433	0.0151	CbGeAlD
Ezogabine—KCNQ5—midbrain—germ cell cancer	0.00421	0.0146	CbGeAlD
Ezogabine—KCNQ4—head—germ cell cancer	0.00375	0.0131	CbGeAlD
Ezogabine—KCNQ3—medulla oblongata—germ cell cancer	0.00369	0.0129	CbGeAlD
Ezogabine—KCNQ5—head—germ cell cancer	0.00365	0.0127	CbGeAlD
Ezogabine—KCNQ4—testis—germ cell cancer	0.00362	0.0126	CbGeAlD
Ezogabine—KCNQ2—gonad—germ cell cancer	0.00361	0.0126	CbGeAlD
Ezogabine—KCNQ2—pituitary gland—germ cell cancer	0.00352	0.0123	CbGeAlD
Ezogabine—KCNQ3—midbrain—germ cell cancer	0.00338	0.0118	CbGeAlD
Ezogabine—KCNQ4—cerebellum—germ cell cancer	0.00335	0.0116	CbGeAlD
Ezogabine—UGT1A3—endocrine gland—germ cell cancer	0.00329	0.0115	CbGeAlD
Ezogabine—KCNQ2—female gonad—germ cell cancer	0.00293	0.0102	CbGeAlD
Ezogabine—KCNQ3—head—germ cell cancer	0.00293	0.0102	CbGeAlD
Ezogabine—UGT1A4—endocrine gland—germ cell cancer	0.0028	0.00975	CbGeAlD
Ezogabine—KCNQ2—endocrine gland—germ cell cancer	0.00273	0.0095	CbGeAlD
Ezogabine—KCNQ4—brain—germ cell cancer	0.00272	0.00946	CbGeAlD
Ezogabine—Dysarthria—Ifosfamide—germ cell cancer	0.0027	0.0133	CcSEcCtD
Ezogabine—KCNQ2—head—germ cell cancer	0.00269	0.00938	CbGeAlD
Ezogabine—KCNQ5—brain—germ cell cancer	0.00264	0.0092	CbGeAlD
Ezogabine—Raised liver function tests—Methotrexate—germ cell cancer	0.00261	0.0129	CcSEcCtD
Ezogabine—Gait disturbance—Ifosfamide—germ cell cancer	0.00261	0.0129	CcSEcCtD
Ezogabine—KCNQ3—cerebellum—germ cell cancer	0.00261	0.00909	CbGeAlD
Ezogabine—KCNQ2—testis—germ cell cancer	0.0026	0.00906	CbGeAlD
Ezogabine—KCNQ5—lymph node—germ cell cancer	0.00255	0.00889	CbGeAlD
Ezogabine—Disorientation—Bleomycin—germ cell cancer	0.00242	0.0119	CcSEcCtD
Ezogabine—KCNQ2—cerebellum—germ cell cancer	0.0024	0.00837	CbGeAlD
Ezogabine—UGT1A9—endocrine gland—germ cell cancer	0.00235	0.00817	CbGeAlD
Ezogabine—Coma—Ifosfamide—germ cell cancer	0.00233	0.0115	CcSEcCtD
Ezogabine—Dysarthria—Cisplatin—germ cell cancer	0.00232	0.0114	CcSEcCtD
Ezogabine—Skin discolouration—Etoposide—germ cell cancer	0.00223	0.011	CcSEcCtD
Ezogabine—KCNQ3—brain—germ cell cancer	0.00212	0.00738	CbGeAlD
Ezogabine—Disorientation—Ifosfamide—germ cell cancer	0.00207	0.0102	CcSEcCtD
Ezogabine—Amnesia—Ifosfamide—germ cell cancer	0.00197	0.00969	CcSEcCtD
Ezogabine—KCNQ2—brain—germ cell cancer	0.00195	0.0068	CbGeAlD
Ezogabine—Encephalopathy—Methotrexate—germ cell cancer	0.00188	0.00924	CcSEcCtD
Ezogabine—Liver function test abnormal—Dactinomycin—germ cell cancer	0.00186	0.00917	CcSEcCtD
Ezogabine—Aphasia—Methotrexate—germ cell cancer	0.00186	0.00915	CcSEcCtD
Ezogabine—Osteoarthritis—Ifosfamide—germ cell cancer	0.00185	0.00911	CcSEcCtD
Ezogabine—Psychotic disorder—Ifosfamide—germ cell cancer	0.00181	0.00889	CcSEcCtD
Ezogabine—Urinary retention—Ifosfamide—germ cell cancer	0.00176	0.00866	CcSEcCtD
Ezogabine—Dysphagia—Dactinomycin—germ cell cancer	0.00175	0.00859	CcSEcCtD
Ezogabine—Amnesia—Cisplatin—germ cell cancer	0.0017	0.00836	CcSEcCtD
Ezogabine—Neutropenia—Dactinomycin—germ cell cancer	0.00163	0.00803	CcSEcCtD
Ezogabine—UGT1A1—endocrine gland—germ cell cancer	0.00161	0.0056	CbGeAlD
Ezogabine—Haematuria—Bleomycin—germ cell cancer	0.00159	0.00783	CcSEcCtD
Ezogabine—Alopecia—Vinblastine—germ cell cancer	0.00157	0.00771	CcSEcCtD
Ezogabine—Dysuria—Ifosfamide—germ cell cancer	0.0015	0.00736	CcSEcCtD
Ezogabine—Ill-defined disorder—Vinblastine—germ cell cancer	0.00143	0.00705	CcSEcCtD
Ezogabine—Infestation NOS—Ifosfamide—germ cell cancer	0.00143	0.00702	CcSEcCtD
Ezogabine—Infestation—Ifosfamide—germ cell cancer	0.00143	0.00702	CcSEcCtD
Ezogabine—Malaise—Vinblastine—germ cell cancer	0.00139	0.00685	CcSEcCtD
Ezogabine—Vertigo—Vinblastine—germ cell cancer	0.00139	0.00683	CcSEcCtD
Ezogabine—Leukopenia—Vinblastine—germ cell cancer	0.00138	0.0068	CcSEcCtD
Ezogabine—Haematuria—Ifosfamide—germ cell cancer	0.00136	0.00669	CcSEcCtD
Ezogabine—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.00135	0.00664	CcSEcCtD
Ezogabine—Skin discolouration—Methotrexate—germ cell cancer	0.00134	0.00657	CcSEcCtD
Ezogabine—Alopecia—Bleomycin—germ cell cancer	0.00132	0.00651	CcSEcCtD
Ezogabine—Discomfort—Vinblastine—germ cell cancer	0.0013	0.00639	CcSEcCtD
Ezogabine—Dysarthria—Methotrexate—germ cell cancer	0.00128	0.00627	CcSEcCtD
Ezogabine—Hallucination—Ifosfamide—germ cell cancer	0.00127	0.00627	CcSEcCtD
Ezogabine—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00126	0.00622	CcSEcCtD
Ezogabine—Dysphagia—Etoposide—germ cell cancer	0.00126	0.00622	CcSEcCtD
Ezogabine—Urethral disorder—Ifosfamide—germ cell cancer	0.00126	0.00618	CcSEcCtD
Ezogabine—Alopecia—Dactinomycin—germ cell cancer	0.00123	0.00607	CcSEcCtD
Ezogabine—Thrombocytopenia—Vinblastine—germ cell cancer	0.00123	0.00607	CcSEcCtD
Ezogabine—Visual impairment—Ifosfamide—germ cell cancer	0.00123	0.00607	CcSEcCtD
Ezogabine—Ill-defined disorder—Bleomycin—germ cell cancer	0.00121	0.00595	CcSEcCtD
Ezogabine—Eye disorder—Ifosfamide—germ cell cancer	0.0012	0.00589	CcSEcCtD
Ezogabine—CYP2A6—cerebellum—germ cell cancer	0.00119	0.00416	CbGeAlD
Ezogabine—Neutropenia—Etoposide—germ cell cancer	0.00118	0.00581	CcSEcCtD
Ezogabine—Malaise—Bleomycin—germ cell cancer	0.00118	0.00579	CcSEcCtD
Ezogabine—Leukopenia—Bleomycin—germ cell cancer	0.00117	0.00574	CcSEcCtD
Ezogabine—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00116	0.00572	CcSEcCtD
Ezogabine—Paraesthesia—Vinblastine—germ cell cancer	0.00113	0.00557	CcSEcCtD
Ezogabine—Alopecia—Ifosfamide—germ cell cancer	0.00113	0.00557	CcSEcCtD
Ezogabine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00113	0.00555	CcSEcCtD
Ezogabine—Infestation NOS—Etoposide—germ cell cancer	0.00113	0.00554	CcSEcCtD
Ezogabine—Infestation—Etoposide—germ cell cancer	0.00113	0.00554	CcSEcCtD
Ezogabine—Mental disorder—Ifosfamide—germ cell cancer	0.00112	0.00552	CcSEcCtD
Ezogabine—Malnutrition—Ifosfamide—germ cell cancer	0.00111	0.00548	CcSEcCtD
Ezogabine—Coma—Methotrexate—germ cell cancer	0.0011	0.00542	CcSEcCtD
Ezogabine—Discomfort—Bleomycin—germ cell cancer	0.0011	0.0054	CcSEcCtD
Ezogabine—Malaise—Dactinomycin—germ cell cancer	0.0011	0.0054	CcSEcCtD
Ezogabine—Urinary tract disorder—Cisplatin—germ cell cancer	0.00109	0.00536	CcSEcCtD
Ezogabine—Leukopenia—Dactinomycin—germ cell cancer	0.00109	0.00536	CcSEcCtD
Ezogabine—Urethral disorder—Cisplatin—germ cell cancer	0.00108	0.00532	CcSEcCtD
Ezogabine—Constipation—Vinblastine—germ cell cancer	0.00108	0.0053	CcSEcCtD
Ezogabine—Confusional state—Bleomycin—germ cell cancer	0.00107	0.00528	CcSEcCtD
Ezogabine—Hepatobiliary disease—Etoposide—germ cell cancer	0.00107	0.00524	CcSEcCtD
Ezogabine—Visual impairment—Cisplatin—germ cell cancer	0.00106	0.00523	CcSEcCtD
Ezogabine—Infection—Bleomycin—germ cell cancer	0.00106	0.0052	CcSEcCtD
Ezogabine—Vision blurred—Ifosfamide—germ cell cancer	0.00105	0.00517	CcSEcCtD
Ezogabine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00104	0.00513	CcSEcCtD
Ezogabine—Feeling abnormal—Vinblastine—germ cell cancer	0.00104	0.00511	CcSEcCtD
Ezogabine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00103	0.00509	CcSEcCtD
Ezogabine—Eye disorder—Cisplatin—germ cell cancer	0.00103	0.00508	CcSEcCtD
Ezogabine—Discomfort—Dactinomycin—germ cell cancer	0.00102	0.00503	CcSEcCtD
Ezogabine—Malaise—Ifosfamide—germ cell cancer	0.00101	0.00495	CcSEcCtD
Ezogabine—Vertigo—Ifosfamide—germ cell cancer	0.001	0.00493	CcSEcCtD
Ezogabine—Urinary tract disorder—Etoposide—germ cell cancer	0.000999	0.00491	CcSEcCtD
Ezogabine—Leukopenia—Ifosfamide—germ cell cancer	0.000998	0.00491	CcSEcCtD
Ezogabine—Urethral disorder—Etoposide—germ cell cancer	0.000991	0.00488	CcSEcCtD
Ezogabine—Infection—Dactinomycin—germ cell cancer	0.000986	0.00485	CcSEcCtD
Ezogabine—Alopecia—Cisplatin—germ cell cancer	0.000975	0.0048	CcSEcCtD
Ezogabine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000972	0.00478	CcSEcCtD
Ezogabine—CYP2A6—brain—germ cell cancer	0.00097	0.00338	CbGeAlD
Ezogabine—Malnutrition—Cisplatin—germ cell cancer	0.000961	0.00473	CcSEcCtD
Ezogabine—Paraesthesia—Bleomycin—germ cell cancer	0.000956	0.0047	CcSEcCtD
Ezogabine—Dyspnoea—Bleomycin—germ cell cancer	0.000949	0.00467	CcSEcCtD
Ezogabine—Eye disorder—Etoposide—germ cell cancer	0.000945	0.00465	CcSEcCtD
Ezogabine—Discomfort—Ifosfamide—germ cell cancer	0.000938	0.00461	CcSEcCtD
Ezogabine—Muscle spasms—Cisplatin—germ cell cancer	0.000924	0.00455	CcSEcCtD
Ezogabine—Confusional state—Ifosfamide—germ cell cancer	0.000917	0.00451	CcSEcCtD
Ezogabine—Vision blurred—Cisplatin—germ cell cancer	0.000906	0.00446	CcSEcCtD
Ezogabine—Asthenia—Vinblastine—germ cell cancer	0.000904	0.00445	CcSEcCtD
Ezogabine—Infection—Ifosfamide—germ cell cancer	0.000904	0.00445	CcSEcCtD
Ezogabine—Tremor—Cisplatin—germ cell cancer	0.0009	0.00443	CcSEcCtD
Ezogabine—Alopecia—Etoposide—germ cell cancer	0.000894	0.0044	CcSEcCtD
Ezogabine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000892	0.00439	CcSEcCtD
Ezogabine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000892	0.00439	CcSEcCtD
Ezogabine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000891	0.00438	CcSEcCtD
Ezogabine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000879	0.00433	CcSEcCtD
Ezogabine—Feeling abnormal—Bleomycin—germ cell cancer	0.000877	0.00432	CcSEcCtD
Ezogabine—Osteoarthritis—Methotrexate—germ cell cancer	0.000876	0.00431	CcSEcCtD
Ezogabine—Malaise—Cisplatin—germ cell cancer	0.000867	0.00426	CcSEcCtD
Ezogabine—Leukopenia—Cisplatin—germ cell cancer	0.00086	0.00423	CcSEcCtD
Ezogabine—Fatigue—Dactinomycin—germ cell cancer	0.000856	0.00421	CcSEcCtD
Ezogabine—Muscle spasms—Etoposide—germ cell cancer	0.000846	0.00416	CcSEcCtD
Ezogabine—Dizziness—Vinblastine—germ cell cancer	0.000833	0.0041	CcSEcCtD
Ezogabine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000818	0.00402	CcSEcCtD
Ezogabine—Paraesthesia—Ifosfamide—germ cell cancer	0.000817	0.00402	CcSEcCtD
Ezogabine—Ill-defined disorder—Etoposide—germ cell cancer	0.000817	0.00402	CcSEcCtD
Ezogabine—Anxiety—Cisplatin—germ cell cancer	0.000815	0.00401	CcSEcCtD
Ezogabine—Dyspnoea—Ifosfamide—germ cell cancer	0.000811	0.00399	CcSEcCtD
Ezogabine—Somnolence—Ifosfamide—germ cell cancer	0.000809	0.00398	CcSEcCtD
Ezogabine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000808	0.00398	CcSEcCtD
Ezogabine—Discomfort—Cisplatin—germ cell cancer	0.000808	0.00398	CcSEcCtD
Ezogabine—Malaise—Etoposide—germ cell cancer	0.000794	0.00391	CcSEcCtD
Ezogabine—Vertigo—Etoposide—germ cell cancer	0.000791	0.00389	CcSEcCtD
Ezogabine—Leukopenia—Etoposide—germ cell cancer	0.000788	0.00388	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000785	0.00386	CcSEcCtD
Ezogabine—Fatigue—Ifosfamide—germ cell cancer	0.000784	0.00386	CcSEcCtD
Ezogabine—Infection—Cisplatin—germ cell cancer	0.000779	0.00383	CcSEcCtD
Ezogabine—Constipation—Ifosfamide—germ cell cancer	0.000778	0.00383	CcSEcCtD
Ezogabine—Loss of consciousness—Etoposide—germ cell cancer	0.000774	0.00381	CcSEcCtD
Ezogabine—Nervous system disorder—Cisplatin—germ cell cancer	0.000769	0.00378	CcSEcCtD
Ezogabine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000768	0.00378	CcSEcCtD
Ezogabine—Asthenia—Bleomycin—germ cell cancer	0.000764	0.00376	CcSEcCtD
Ezogabine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000758	0.00373	CcSEcCtD
Ezogabine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00075	0.00369	CcSEcCtD
Ezogabine—Nausea—Vinblastine—germ cell cancer	0.000749	0.00368	CcSEcCtD
Ezogabine—Discomfort—Etoposide—germ cell cancer	0.00074	0.00364	CcSEcCtD
Ezogabine—Confusional state—Etoposide—germ cell cancer	0.000724	0.00356	CcSEcCtD
Ezogabine—Infection—Etoposide—germ cell cancer	0.000714	0.00351	CcSEcCtD
Ezogabine—Asthenia—Dactinomycin—germ cell cancer	0.000712	0.0035	CcSEcCtD
Ezogabine—Neutropenia—Methotrexate—germ cell cancer	0.000708	0.00348	CcSEcCtD
Ezogabine—Dysuria—Methotrexate—germ cell cancer	0.000708	0.00348	CcSEcCtD
Ezogabine—Paraesthesia—Cisplatin—germ cell cancer	0.000704	0.00346	CcSEcCtD
Ezogabine—Thrombocytopenia—Etoposide—germ cell cancer	0.000703	0.00346	CcSEcCtD
Ezogabine—Dyspnoea—Cisplatin—germ cell cancer	0.000699	0.00344	CcSEcCtD
Ezogabine—Hyperhidrosis—Etoposide—germ cell cancer	0.000695	0.00342	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000677	0.00333	CcSEcCtD
Ezogabine—Infestation NOS—Methotrexate—germ cell cancer	0.000675	0.00332	CcSEcCtD
Ezogabine—Infestation—Methotrexate—germ cell cancer	0.000675	0.00332	CcSEcCtD
Ezogabine—Rash—Bleomycin—germ cell cancer	0.000671	0.0033	CcSEcCtD
Ezogabine—Dermatitis—Bleomycin—germ cell cancer	0.00067	0.0033	CcSEcCtD
Ezogabine—Asthenia—Ifosfamide—germ cell cancer	0.000653	0.00321	CcSEcCtD
Ezogabine—Feeling abnormal—Cisplatin—germ cell cancer	0.000646	0.00318	CcSEcCtD
Ezogabine—Paraesthesia—Etoposide—germ cell cancer	0.000645	0.00317	CcSEcCtD
Ezogabine—Haematuria—Methotrexate—germ cell cancer	0.000643	0.00317	CcSEcCtD
Ezogabine—Dyspnoea—Etoposide—germ cell cancer	0.000641	0.00315	CcSEcCtD
Ezogabine—Somnolence—Etoposide—germ cell cancer	0.000639	0.00314	CcSEcCtD
Ezogabine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000638	0.00314	CcSEcCtD
Ezogabine—Nausea—Bleomycin—germ cell cancer	0.000632	0.00311	CcSEcCtD
Ezogabine—Rash—Dactinomycin—germ cell cancer	0.000626	0.00308	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00062	0.00305	CcSEcCtD
Ezogabine—Fatigue—Etoposide—germ cell cancer	0.000619	0.00305	CcSEcCtD
Ezogabine—Constipation—Etoposide—germ cell cancer	0.000614	0.00302	CcSEcCtD
Ezogabine—Dizziness—Ifosfamide—germ cell cancer	0.000602	0.00296	CcSEcCtD
Ezogabine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000598	0.00294	CcSEcCtD
Ezogabine—Urethral disorder—Methotrexate—germ cell cancer	0.000594	0.00292	CcSEcCtD
Ezogabine—Feeling abnormal—Etoposide—germ cell cancer	0.000592	0.00291	CcSEcCtD
Ezogabine—Nausea—Dactinomycin—germ cell cancer	0.00059	0.0029	CcSEcCtD
Ezogabine—Visual impairment—Methotrexate—germ cell cancer	0.000584	0.00287	CcSEcCtD
Ezogabine—Rash—Ifosfamide—germ cell cancer	0.000574	0.00282	CcSEcCtD
Ezogabine—Dermatitis—Ifosfamide—germ cell cancer	0.000573	0.00282	CcSEcCtD
Ezogabine—Eye disorder—Methotrexate—germ cell cancer	0.000566	0.00279	CcSEcCtD
Ezogabine—Asthenia—Cisplatin—germ cell cancer	0.000563	0.00277	CcSEcCtD
Ezogabine—Nausea—Ifosfamide—germ cell cancer	0.00054	0.00266	CcSEcCtD
Ezogabine—Alopecia—Methotrexate—germ cell cancer	0.000535	0.00263	CcSEcCtD
Ezogabine—Mental disorder—Methotrexate—germ cell cancer	0.000531	0.00261	CcSEcCtD
Ezogabine—Malnutrition—Methotrexate—germ cell cancer	0.000527	0.00259	CcSEcCtD
Ezogabine—Asthenia—Etoposide—germ cell cancer	0.000515	0.00254	CcSEcCtD
Ezogabine—Vision blurred—Methotrexate—germ cell cancer	0.000497	0.00244	CcSEcCtD
Ezogabine—Rash—Cisplatin—germ cell cancer	0.000494	0.00243	CcSEcCtD
Ezogabine—Dermatitis—Cisplatin—germ cell cancer	0.000494	0.00243	CcSEcCtD
Ezogabine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000489	0.00241	CcSEcCtD
Ezogabine—Malaise—Methotrexate—germ cell cancer	0.000475	0.00234	CcSEcCtD
Ezogabine—Dizziness—Etoposide—germ cell cancer	0.000475	0.00234	CcSEcCtD
Ezogabine—Vertigo—Methotrexate—germ cell cancer	0.000474	0.00233	CcSEcCtD
Ezogabine—Leukopenia—Methotrexate—germ cell cancer	0.000472	0.00232	CcSEcCtD
Ezogabine—Nausea—Cisplatin—germ cell cancer	0.000466	0.00229	CcSEcCtD
Ezogabine—Rash—Etoposide—germ cell cancer	0.000453	0.00223	CcSEcCtD
Ezogabine—Dermatitis—Etoposide—germ cell cancer	0.000453	0.00223	CcSEcCtD
Ezogabine—Discomfort—Methotrexate—germ cell cancer	0.000444	0.00218	CcSEcCtD
Ezogabine—Confusional state—Methotrexate—germ cell cancer	0.000434	0.00213	CcSEcCtD
Ezogabine—Infection—Methotrexate—germ cell cancer	0.000428	0.0021	CcSEcCtD
Ezogabine—Nausea—Etoposide—germ cell cancer	0.000427	0.0021	CcSEcCtD
Ezogabine—Nervous system disorder—Methotrexate—germ cell cancer	0.000422	0.00208	CcSEcCtD
Ezogabine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000421	0.00207	CcSEcCtD
Ezogabine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000416	0.00205	CcSEcCtD
Ezogabine—Paraesthesia—Methotrexate—germ cell cancer	0.000386	0.0019	CcSEcCtD
Ezogabine—Dyspnoea—Methotrexate—germ cell cancer	0.000384	0.00189	CcSEcCtD
Ezogabine—Somnolence—Methotrexate—germ cell cancer	0.000383	0.00188	CcSEcCtD
Ezogabine—Dyspepsia—Methotrexate—germ cell cancer	0.000379	0.00186	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000372	0.00183	CcSEcCtD
Ezogabine—Fatigue—Methotrexate—germ cell cancer	0.000371	0.00183	CcSEcCtD
Ezogabine—Feeling abnormal—Methotrexate—germ cell cancer	0.000355	0.00174	CcSEcCtD
Ezogabine—Asthenia—Methotrexate—germ cell cancer	0.000309	0.00152	CcSEcCtD
Ezogabine—Dizziness—Methotrexate—germ cell cancer	0.000285	0.0014	CcSEcCtD
Ezogabine—Rash—Methotrexate—germ cell cancer	0.000271	0.00133	CcSEcCtD
Ezogabine—Dermatitis—Methotrexate—germ cell cancer	0.000271	0.00133	CcSEcCtD
Ezogabine—Nausea—Methotrexate—germ cell cancer	0.000256	0.00126	CcSEcCtD
